TY - JOUR
T1 - Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport
AU - Takamatsu, Yuki
AU - Yoshikawa, Tomoki
AU - Kurosu, Takeshi
AU - Fukushi, Shuetsu
AU - Nagata, Noriyo
AU - Shimojima, Masayuki
AU - Ebihara, Hideki
AU - Saijo, Masayuki
AU - Noda, Takeshi
N1 - Funding Information:
The work was supported by Japan Society for the Promotion of Science, JSPS Grant numbers 18J01631, 19K16666, and 21K07059; AMED under Grant Number 20wm0325023j0002, 21wm0325023j0002, 21fm0208101j0205, and JP22fm0208101; The Ichiro Kanehara Foundation for the Promotion of Medical Science & Medical Care (No. 19KI268); by MSD Life Science Foundation ID-022, AID-06; The Japan Research Foundation for Clinical Pharmacology; TERUMO LIFE SCIENCE FOUNDATION 19-III455; The Waksman Foundation research grant; The Novartis foundation research grant; The Naito foundation grant for the next generation researcher; Takeda Science Foundation; the Joint Usage/Research Center on Tropical Disease (2019-Ippan-24, 2020-Ippan-28, and 2021-Ippan-21); the Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences Kyoto University (2020, 2021) (to Y.T.); AMED, Research Program on Emerging and Re-emerging Infectious Diseases (20fk0108270h0001; 21wm0325023j0002); JSPS Core-to-Core Program A, the Advanced Research Networks; the JST Core Research for Evolutional Science and Technology (JPMJCR20HA); Grant for Joint Research Project of the Institute of Medical Science, University of Tokyo; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences Kyoto University; the Joint Usage/ Research Center on Tropical Disease, Nagasaki University; the Uehara Memorial Foundation; the Daiichi Sankyo Foundation of Life Science; and by the Takeda Science Foundation (to T.N.).
Funding Information:
We thank Stephan Becker and Larissa Kolesnikova for fruitful discussion and providing materials. We are grateful to Dirk Becker, Sonja Heck, Astrid Herwig, and Katharina Kowalski at Philipps-Universität Marburg, Germany; Michiyo Kataoka, Momoko Ogata, Satoko Sugimoto, and Masayasu Misu at National Institute of Infectious Diseases, Japan, for technical assistance. BSL-4 work would not have been possible without the supervision of Markus Eickmann and technical support from Michael Schmidt and Gotthard Ludwig at Philipps-Universität Marburg, Germany. The work was supported by Japan Society for the Promotion of Science, JSPS Grant numbers 18J01631, 19K16666, and 21K07059; AMED under Grant Number 20wm0325023j0002, 21wm0325023j0002, 21fm0208101j0205, and JP22fm0208101; The Ichiro Kanehara Foundation for the Promotion of Medical Science & Medical Care (No. 19KI268); by MSD Life Science Foundation ID-022, AID-06; The Japan Research Foundation for Clinical Pharmacology; TERUMO LIFE SCIENCE FOUNDATION 19-III455; The Waksman Foundation research grant; The Novartis foundation research grant; The Naito foundation grant for the next generation researcher; Takeda Science Foundation; the Joint Usage/Research Center on Tropical Disease (2019-Ippan-24, 2020-Ippan-28, and 2021-Ippan-21); the Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences Kyoto University (2020, 2021) (to Y.T.); AMED, Research Program on Emerging and Re-emerging Infectious Diseases (20fk0108270h0001; 21wm0325023j0002); JSPS Core-to-Core Program A, the Advanced Research Networks; the JST Core Research for Evolutional Science and Technology (JPMJCR20HA); Grant for Joint Research Project of the Institute of Medical Science, University of Tokyo; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences Kyoto University; the Joint Usage/ Research Center on Tropical Disease, Nagasaki University; the Uehara Memorial Foundation; the Daiichi Sankyo Foundation of Life Science; and by the Takeda Science Foundation (to T.N.).
Publisher Copyright:
Copyright © 2022 American Society for Microbiology. All Rights Reserved.
PY - 2022/9
Y1 - 2022/9
N2 - Ebola virus (EBOV) VP30 regulates viral genome transcription and replication by switching its phosphorylation status. However, the importance of VP30 phosphorylation and dephosphorylation in other viral replication processes such as nucleocapsid and virion assembly is unclear. Interestingly, VP30 is predominantly dephosphorylated by cellular phosphatases in viral inclusions, while it is phosphorylated in the released virions. Thus, uncertainties regarding how VP30 phosphorylation in nucleocapsids is achieved and whether VP30 phosphorylation provides any advantages in later steps in viral replication have arisen. In the present study, to characterize the roles of VP30 phosphorylation in nucleocapsid formation, we used electron microscopic analyses and live cell imaging systems. We identified VP30 localized to the surface of protrusions surrounding nucleoprotein (NP)forming helical structures in the nucleocapsid, suggesting the involvement in assembly and transport of nucleocapsids. Interestingly, VP30 phosphorylation facilitated its association with nucleocapsid-like structures (NCLSs). On the contrary, VP30 phosphorylation does not influence the transport characteristics and NCLS number leaving from and coming back into viral inclusions, indicating that the phosphorylation status of VP30 is not a prerequisite for NCLS departure. Moreover, the phosphorylation status of VP30 did not cause major differences in nucleocapsid transport in authentic EBOV-infected cells. In the following budding step, the association of VP30 and its phosphorylation status did not influence the budding efficiency of virus-like particles. Taken together, it is plausible that EBOV may utilize the phosphorylation of VP30 for its selective association with nucleocapsids, without affecting nucleocapsid transport and virion budding processes. IMPORTANCE Ebola virus (EBOV) causes severe fevers with unusually high case fatality rates. The nucleocapsid provides the template for viral genome transcription and replication. Thus, understanding the regulatory mechanism behind its formation is important for the development of novel therapeutic approaches. Previously, we established a live-cell imaging system based on the ectopic expression of viral fluorescent fusion proteins, allowing the visualization and characterization of intracytoplasmic transport of nucleocapsid-like structures. EBOV VP30 is an essential transcriptional factor for viral genome synthesis, and, although its role in viral genome transcription and replication is well understood, the functional importance of VP30 phosphorylation in assembly of nucleocapsids is still unclear. Our work determines the localization of VP30 at the surface of ruffled nucleocapsids, which differs from the localization of polymerase in EBOV-infected cells. This study sheds light on the novel role of VP30 phosphorylation in nucleocapsid assembly, which is an important prerequisite for virion formation.
AB - Ebola virus (EBOV) VP30 regulates viral genome transcription and replication by switching its phosphorylation status. However, the importance of VP30 phosphorylation and dephosphorylation in other viral replication processes such as nucleocapsid and virion assembly is unclear. Interestingly, VP30 is predominantly dephosphorylated by cellular phosphatases in viral inclusions, while it is phosphorylated in the released virions. Thus, uncertainties regarding how VP30 phosphorylation in nucleocapsids is achieved and whether VP30 phosphorylation provides any advantages in later steps in viral replication have arisen. In the present study, to characterize the roles of VP30 phosphorylation in nucleocapsid formation, we used electron microscopic analyses and live cell imaging systems. We identified VP30 localized to the surface of protrusions surrounding nucleoprotein (NP)forming helical structures in the nucleocapsid, suggesting the involvement in assembly and transport of nucleocapsids. Interestingly, VP30 phosphorylation facilitated its association with nucleocapsid-like structures (NCLSs). On the contrary, VP30 phosphorylation does not influence the transport characteristics and NCLS number leaving from and coming back into viral inclusions, indicating that the phosphorylation status of VP30 is not a prerequisite for NCLS departure. Moreover, the phosphorylation status of VP30 did not cause major differences in nucleocapsid transport in authentic EBOV-infected cells. In the following budding step, the association of VP30 and its phosphorylation status did not influence the budding efficiency of virus-like particles. Taken together, it is plausible that EBOV may utilize the phosphorylation of VP30 for its selective association with nucleocapsids, without affecting nucleocapsid transport and virion budding processes. IMPORTANCE Ebola virus (EBOV) causes severe fevers with unusually high case fatality rates. The nucleocapsid provides the template for viral genome transcription and replication. Thus, understanding the regulatory mechanism behind its formation is important for the development of novel therapeutic approaches. Previously, we established a live-cell imaging system based on the ectopic expression of viral fluorescent fusion proteins, allowing the visualization and characterization of intracytoplasmic transport of nucleocapsid-like structures. EBOV VP30 is an essential transcriptional factor for viral genome synthesis, and, although its role in viral genome transcription and replication is well understood, the functional importance of VP30 phosphorylation in assembly of nucleocapsids is still unclear. Our work determines the localization of VP30 at the surface of ruffled nucleocapsids, which differs from the localization of polymerase in EBOV-infected cells. This study sheds light on the novel role of VP30 phosphorylation in nucleocapsid assembly, which is an important prerequisite for virion formation.
KW - Ebola virus
KW - VP30
KW - assembly
KW - nucleocapsid
KW - nucleocapsid-like structure
KW - phosphorylation
KW - transport
UR - http://www.scopus.com/inward/record.url?scp=85138448957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138448957&partnerID=8YFLogxK
U2 - 10.1128/jvi.01083-22
DO - 10.1128/jvi.01083-22
M3 - Article
C2 - 35993739
AN - SCOPUS:85138448957
SN - 0022-538X
VL - 96
JO - Journal of virology
JF - Journal of virology
IS - 17
ER -